BioCentury | Aug 14, 2019
Financial News

D&D raises $137M to fund inflammation tech out of JHU

...fall, Urban said. The unifying factor that ties the subsidiaries together, she added, is inflammation. Octave Life Sciences...
BioCentury | Jul 20, 2018
Financial News

Neuraly raises $36M series A to develop microglia-targeted PD candidate

...Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&Pharma joined fellow new investors Octave Life Sciences...
BioCentury | Jul 18, 2018
Financial News

Neuraly debuts with $36M to target neurodegenerative diseases

...Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&Pharma joined fellow new investors Octave Life Sciences...
Items per page:
1 - 3 of 3
BioCentury | Aug 14, 2019
Financial News

D&D raises $137M to fund inflammation tech out of JHU

...fall, Urban said. The unifying factor that ties the subsidiaries together, she added, is inflammation. Octave Life Sciences...
BioCentury | Jul 20, 2018
Financial News

Neuraly raises $36M series A to develop microglia-targeted PD candidate

...Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&Pharma joined fellow new investors Octave Life Sciences...
BioCentury | Jul 18, 2018
Financial News

Neuraly debuts with $36M to target neurodegenerative diseases

...Smilegate, InterVest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&Pharma joined fellow new investors Octave Life Sciences...
Items per page:
1 - 3 of 3